Encyt Technologies, Inc. Announces a Potential Breakthrough Approach to Enhance Immunotherapy TreatmentPR Newswire (press release)MEMBERTOU, Nova Scotia, July 5, 2017 /PRNewswire/ — Encyt Technologies, Inc., a leading biotech cancer research organizat… Continue reading
Genetic Literacy Project |
Redefining natural selection: How synthetic biology may solve sustainability challenges in food, fuel and health
Genetic Literacy Project [S]ynthetic biology] is poised to change how we feed ourselves, clothe ourselves, fuel ourselves—and possibly even change our very selves. While scientists have for decades been able to practice basic genetic engineering—knocking out a gene or moving … |
|
Celsion Announces Completion of OVATION Study and Provides Update on its Immunotherapy Trial in Advanced …
Nasdaq LAWRENCEVILLE, N.J., July 05, 2017 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ:CLSN) today provided an update on its Phase Ib dose escalating clinical trial (the OVATION Study) combining GEN-1, the Company’s IL-12 gene-mediated … |
|
New Frontier in Cancer Care: Turning blood into living drugs
Brattleboro Reformer As CAR–T cells swarm the cancer, an immune overreaction called “cytokine release syndrome” can trigger high fevers and plummeting blood pressure and in severe cases organ damage. Some patients also experience confusion, hallucinations or other … |
|
New Frontier in Cancer Care: Turning blood into living drugs | The …
The Manchester Journal SEATTLE — Ken Shefveland’s body was swollen with cancer, treatment after treatment failing until doctors gambled on a radical approach: They removed some … |
Spectrum |
CRISPR goes wild, and scientists debate its fidelity
Spectrum The gene-editing tool CRISPR may cause thousands of unintended mutations, but critics say it’s way too soon to accuse it of infidelity. A two-page study, published 30 May in Nature Methods, put biology’s hottest technique in the crosshairs, questioning … |
|
Embryonic stem cells to be available for medical use in Japan by next March
The Japan Times KYOTO – Embryonic stem cells for regenerative medicine will become available to medical institutions by the March 2018 end of fiscal 2017, Hirofumi Suemori, associate professor at Kyoto University’s Institute for Frontier Life and Medical Sciences, has … |
Drug Target Review |
Extra funding for nanomaterials for cancer immunotherapy research
Drug Target Review The German Research Foundation (DFG) has agreed to fund the Mainz-based Collaborative Research Center (CRC) 1066 “Nanodimensional Polymer Therapeutics for Tumour Therapy” involved in the development of nanomaterials for cancer … |